Quarterly ResultOct 30, 2026, 11:01 AM
Thermo Fisher Q3 Revenue $12.14B, EPS $4.64; Nine-Month Revenue $35.14B
AI Summary
Thermo Fisher Scientific Inc. reported its third-quarter and nine-month financial results for 2026. The company saw a year-over-year increase in both quarterly and year-to-date revenues and earnings per share. Total assets and long-term obligations also saw increases, with significant investment in acquisitions during the nine-month period.
Key Highlights
- Thermo Fisher Scientific reported Q3 2026 revenues of $12.14B, up 9.1% YoY.
- Nine-month revenues reached $35.14B, a 8.7% increase compared to the prior year.
- Q3 2026 diluted EPS was $4.64, compared to $4.27 in Q3 2025.
- Nine-month diluted EPS was $13.75, up from $12.53 in the same period last year.
- Total assets grew to $114.23B as of September 26, 2026, from $110.34B at year-end 2025.
- Long-term obligations increased to $39.11B from $35.85B.
- Acquisitions, net of cash acquired, amounted to $8.88B for the nine months ended September 26, 2026.
Price Impact
More from TMO